Effect of Pharmacogenetics Variations on Praziquantel Plasma Concentrations and Schistosomiasis Treatment Outcomes Among Infected School-Aged Children in Tanzania

by Rajabu Hussein Mnkugwe, Rajabu Hussein Mnkugwe, Omary Minzi, Safari Kinung’hi, Appolinary Kamuhabwa, Eleni Aklillu
Published 2021-08-01

Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical t...

by Rajabu Hussein Mnkugwe, Omary Minzi, Safari Kinung'hi, Appolinary Kamuhabwa, Eleni Aklillu
Published 2020-09-01

Prevalence and correlates of intestinal schistosomiasis infection among school-aged children in North-Western Tanzania.

by Rajabu Hussein Mnkugwe, Omary S Minzi, Safari M Kinung'hi, Appolinary A Kamuhabwa, Eleni Aklillu
Published 2020-01-01

Efficacy and Safety of Praziquantel for Treatment of <i>Schistosoma mansoni</i> Infection among School Children in Tanzania

by Rajabu Hussein Mnkugwe, Omary S. Minzi, Safari M. Kinung’hi, Appolinary A. Kamuhabwa, Eleni Aklillu
Published 2019-12-01

Optimal single sampling time-point for monitoring of praziquantel exposure in children

by Rajabu Hussein Mnkugwe, Eliford Ngaimisi Kitabi, Safari Kinung’hi, Appolinary A. R. Kamuhabwa, Omary Mashiku Minzi, Eleni Aklillu
Published 2021-09-01

Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of <i>Schistosoma mansoni</i> Infection

by Omary Mashiku Minzi, Rajabu Hussein Mnkugwe, Eliford Ngaimisi, Safari Kinung’hi, Anna Hansson, Anton Pohanka, Appolinary Kamuhabwa, Eleni Aklillu
Published 2021-04-01